Inpharma Weekly


ISSN: 1173-8324        年代:2004
当前卷期:Volume &NA;  issue 1432-1433     [ 查看所有卷期 ]

年代:2004
 
     Volume &NA;  issue 1419   
     Volume &NA;  issue 1420   
     Volume &NA;  issue 1421   
     Volume &NA;  issue 1422   
     Volume &NA;  issue 1423   
     Volume &NA;  issue 1424   
     Volume &NA;  issue 1425   
     Volume &NA;  issue 1426   
     Volume &NA;  issue 1427   
     Volume &NA;  issue 1428   
     Volume &NA;  issue 1429   
     Volume &NA;  issue 1430   
     Volume &NA;  issue 1431   
     Volume &NA;  issue 1432-1433
     Volume &NA;  issue 1434   
     Volume &NA;  issue 1435   
     Volume &NA;  issue 1436   
     Volume &NA;  issue 1437   
     Volume &NA;  issue 1438   
     Volume &NA;  issue 1439   
     Volume &NA;  issue 1440   
     Volume &NA;  issue 1441   
     Volume &NA;  issue 1442   
     Volume &NA;  issue 1443   
     Volume &NA;  issue 1444   
     Volume &NA;  issue 1445   
     Volume &NA;  issue 1446   
     Volume &NA;  issue 1447   
     Volume &NA;  issue 1448   
     Volume &NA;  issue 1449   
     Volume &NA;  issue 1450   
     Volume &NA;  issue 1451   
     Volume &NA;  issue 1452   
     Volume &NA;  issue 1453   
     Volume &NA;  issue 1454   
     Volume &NA;  issue 1455   
     Volume &NA;  issue 1456   
     Volume &NA;  issue 1457   
     Volume &NA;  issue 1458   
     Volume &NA;  issue 1459   
     Volume &NA;  issue 1460   
     Volume &NA;  issue 1461   
     Volume &NA;  issue 1462   
     Volume &NA;  issue 1463   
     Volume &NA;  issue 1464   
     Volume &NA;  issue 1465   
     Volume &NA;  issue 1466   
     Volume &NA;  issue 1467   
     Volume &NA;  issue 1468   
1. Immunotherapies for cancer reviewed
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  2-2

&NA;,  

Preview

2. A record £3.5 billion was spent by the British pharmaceutical industry in 2003 in the search for new medicines,
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  3-3

&NA;,  

Preview

3. Daily prophylactic medications were prescribed to just over 50% of paediatric patients presenting with migraine to a US paediatric neurology clinic between January and June 2001,
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  4-4

&NA;,  

Preview

4. Salmeterol/fluticasone propionate single inhaler administration potentially cost saving
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  5-6

L Hunt,  

Preview

5. Routine antiretroviral resistance testing of value in HIV infections
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  6-6

&NA;,  

Preview

6. Adherence to antipsychotics low despite health, cost benefits
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  7-7

&NA;,  

Preview

7. Cost of epilepsy variable in Italy
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  8-8

&NA;,  

Preview

8. The phytostanol analogue FM VP4*, a cholesterol absorption inhibitor, significantly lowered LDL-cholesterol levels,
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  9-9

&NA;,  

Preview

9. AMD 3100*induces rapid mobilisation of CD34+ cells
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  10-10

&NA;,  

Preview

10. BLP25 liposomal vaccine [L-BLP25]*, a synthetic MUC1 peptide vaccine, enhances survival in patients with non-small-cell lung cancer,
  Inpharma Weekly,   Volume  &NA;,   Issue  1432-1433,   2004,   Page  11-11

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共22条